chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fibrin D dimer increased, Lung opacity, PO2 decreased, Red blood cell sedimentation rate increased, Troponin I increased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 05/10 Janssen, dose #1 10/08 pt admit to medicine cc: fall dx: COVID-19 penumonia.LOS: 10 days 10/08 CXR impression: Hazy density in the left mid to lower lung zone with more subtle patchy density in the left mid lung, which could represent pneumonia. 10/08 CTA PE impression: 1. No CT evidence of a large central pulmonary embolism. 2. Diffuse glass opacities throughout the lung parenchyma.  Finding may be consistent with the patient's positive COVID status. 3. Emphysematous lung parenchyma. 4. Atherosclerosis. 10/08 BNP: 68.7 10/08 TROPONIN I: 0.037 10/08 COVID swab, result: detected 10/08 SARS-COV-2 Variant Sequencing result: pending 10/08 FIBRINOGEN: 384 10/08 DDIMER: 1.21 10/08 CRP: 15.527 10/08 ABG: i-pH 7.50, i-PCo2 37.3, i-PO2 46, i-HCO3 28.9 10/08 FIBRINOGEN: 281 10/08 DDIMER: 1.25 10/08 ESR: 19 10/08 FERRITIN: 753.8 10/09 PROCALCITONIN <0.05 10/09 LACTIC ACID: 0.91 10/09 SARS-COV-2 Variant Sequencing result: 2500.0 10/09 troponin i: 0.040 10/09 SARS-CCOV-2-IgG: 0.03 10/10 FIBRINOGEN: 378 10/10 DDIMER: 1.20 10/10 ESR: 33 10/11 FIBRINOGEN: 288 10/11 DDIMER: 0.97 10/11 ESR: 19 10/12 COVID swab, result: detected 10/12 pt cc: exposure: unknown 10/12 FIBRINOGEN: 308 10/12 DDIMER: 1.03 1012 ESR: 29 10/13 FIBRINOGEN: 242 10/13 DDIMER: 1.29 10/13 ESR: 31 10/14 FIBRINOGEN: 245 10/15 DDIMER: 1.50 10/15 ESR: 23 10/15 FIBRINOGEN: 208 10/15 DDIMER: 1.76 10/15 ESR: 21 10/16 FIBRINOGEN: 247 10/16 DDIMER: 1.71 10/16 ESR: 30 10/17 FIBRINOGEN: 255 10/17 DDIMER: 1.40 10/17 ESR: 15
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram pulmonary abnormal, Blood bicarbonate normal, Blood fibrinogen increased, Blood gases, Blood pH normal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, COVID-19, Cardiac failure chronic, Cardiomegaly, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fibrin D dimer, Inappropriate schedule of product administration, International normalised ratio increased, Lung infiltration
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy mediastinal, PCO2 decreased, PO2 decreased, Pleural effusion, Procalcitonin
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Prothrombin time prolonged, Pulmonary congestion, Red blood cell sedimentation rate increased, SARS-CoV-2 antibody test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I increased
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/16, Pfizer dose #1 02/06, Pfizer, dose #2 10/08 ESR: 41 10/08 BNP: 243.6 10/08 COVID swab, result: detected 10/08 PT/INR: 12.8/1.14 10/08 pt cc: chest pain exposure: unknown 10/08 pt admit to medicine cc: "sharp  non-radiating CP" dx: AECHF, COVID+ LOS: 4 days 10/08 ABG: i-pH 7.41, i-PCo2 33.1 i-PO2 77, i-HC03 21.0 10/08 TROPONIN I: 0.198 10/08 CTA PE impression: 1. Negative for pulmonary embolus. 2. nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential pulmonary edema. 3. New and enlarging upper mediastinal  lymph nodes now measure up to 15 mm in short axis. 10/09 CXR Impression: Slightly decreased mild pulmonary vascular congestion with associated cardiomegaly. 10/08 CXR impression: Negative for pulmonary embolus. 2. Nonspecific bilateral lower lobe and RIGHT middle lobe slight patchy infiltrates with large, RIGHT greater than LEFT pleural effusions. Correlate for potential edema. 3. New and enlarging upper mediastinal lymph nodes now measure up to 15 mm in short axis. 10/09 SARS-COV2IIgG: 0.67 10/09 procalcitonin: 0.09 10/09 ESR: 43 10/09 FIBRINOGEN: 469 10/09 DDIMER:  0.81 10/09 SARS-COV-2 Variant Sequencing results: pending 10/10 FIBRINOGEN: 480 10/10 DDIMER: 0.42 10/10 ESR: 58 10/11 FIBRINOGEN: 449 10/11 DDIMER: 0.45 10/11 ESR: 33 10/12 COVID swab, result: NOT detected
Age: 90.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Unevaluable event
Clinical narrative: Narrative: None stated.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 07/22 Pfizer, dose #1 08/12 Pfizer, dose #2 10/08 COVID swab, result: detected 10/06 pt cc: cough, rhinorrhea exposure: unknown 10/08 SARS-COV-2 Variant Sequencing result: pending
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Asthma, Bladder catheterisation, Computerised tomogram head normal, Coordination abnormal
Clinical narrative: Narrative: Date of Admission: 04/25/21 Date of Discharge: 5/5/21 Admission Diagnoses: 1. Generalized weakness and fatigue 2. Multiple falls 3. Lower extremity weakness 4. Asthma 5. HTN Discharge Diagnoses: 1. Multiple falls 2. Generalized weakness and fatigue 3. Near syncopal episode 4. Asthma 5. HTN Brief History and Hospital Course: 80 yr old male, presented with generalized weakness, fatigue and multiple falls, was seen by Physical Therapy, condition stabilized, discharged to SNF. Advised to followup with his PCP within one week. HPI: patient presented to ER w/ c/o multiple falls, weakness and lack of coordination. Told ER he had gotten COVID vaccine last month and his issues may have started then. CT head and MRI brain showed not acute abnormalities. Patient has known hx of PMR and vestibular dysfunction. Reports he also has new RUE tremor that started after COVID vaccine. Neuro evaluated patient and started trial of sinemet. Also found to have urinary retention and UTI and had foley placed and started on course of antibiotics. Sent to SNF for further therapy and medical management.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Fatigue, Hypertension, Magnetic resonance imaging head normal, Muscular weakness
Clinical narrative: Narrative: Date of Admission: 04/25/21 Date of Discharge: 5/5/21 Admission Diagnoses: 1. Generalized weakness and fatigue 2. Multiple falls 3. Lower extremity weakness 4. Asthma 5. HTN Discharge Diagnoses: 1. Multiple falls 2. Generalized weakness and fatigue 3. Near syncopal episode 4. Asthma 5. HTN Brief History and Hospital Course: 80 yr old male, presented with generalized weakness, fatigue and multiple falls, was seen by Physical Therapy, condition stabilized, discharged to SNF. Advised to followup with his PCP within one week. HPI: patient presented to ER w/ c/o multiple falls, weakness and lack of coordination. Told ER he had gotten COVID vaccine last month and his issues may have started then. CT head and MRI brain showed not acute abnormalities. Patient has known hx of PMR and vestibular dysfunction. Reports he also has new RUE tremor that started after COVID vaccine. Neuro evaluated patient and started trial of sinemet. Also found to have urinary retention and UTI and had foley placed and started on course of antibiotics. Sent to SNF for further therapy and medical management.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Presyncope, Tremor, Urinary retention, Urinary tract infection
Clinical narrative: Narrative: Date of Admission: 04/25/21 Date of Discharge: 5/5/21 Admission Diagnoses: 1. Generalized weakness and fatigue 2. Multiple falls 3. Lower extremity weakness 4. Asthma 5. HTN Discharge Diagnoses: 1. Multiple falls 2. Generalized weakness and fatigue 3. Near syncopal episode 4. Asthma 5. HTN Brief History and Hospital Course: 80 yr old male, presented with generalized weakness, fatigue and multiple falls, was seen by Physical Therapy, condition stabilized, discharged to SNF. Advised to followup with his PCP within one week. HPI: patient presented to ER w/ c/o multiple falls, weakness and lack of coordination. Told ER he had gotten COVID vaccine last month and his issues may have started then. CT head and MRI brain showed not acute abnormalities. Patient has known hx of PMR and vestibular dysfunction. Reports he also has new RUE tremor that started after COVID vaccine. Neuro evaluated patient and started trial of sinemet. Also found to have urinary retention and UTI and had foley placed and started on course of antibiotics. Sent to SNF for further therapy and medical management.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Aphasia, Asthenia, Cognitive disorder, Death, Dysphagia
Clinical narrative: Narrative: 87yo male in home hospice care died on 8/29/2021. Pt had a hx of a debilitating hemorrhagic stroke in May that results in weakness, dysphagia, cognitive impairment, and aphasia. Patient had a prolonged hospitalization and then completed short-term rehab. He was readmitted to facility on 8/11/21. He then transfered to home hospice on 8/25/21 and died on 8/29/21. Pt had received covid 19 vaccines on 4/13/21 & 5/11/21. Death is not related to vaccines.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Haemorrhagic stroke
Clinical narrative: Narrative: 87yo male in home hospice care died on 8/29/2021. Pt had a hx of a debilitating hemorrhagic stroke in May that results in weakness, dysphagia, cognitive impairment, and aphasia. Patient had a prolonged hospitalization and then completed short-term rehab. He was readmitted to facility on 8/11/21. He then transfered to home hospice on 8/25/21 and died on 8/29/21. Pt had received covid 19 vaccines on 4/13/21 & 5/11/21. Death is not related to vaccines.
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Admitted for COVID-19 ON 8/29/21
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Eye swelling, Inappropriate schedule of product administration, Palpitations, Rash
Clinical narrative: Pt experienced rash on nose, eye swelling, and chest pain/palpitations. Dose 1 of the vaccine was given 05/12/2021 and dose 2 on 8/3/21.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Chest pain, Death
Clinical narrative: Narrative: 76 yo male with metastatic prostate cancer to various bones, CAD s/p CABG, HTN, HLP, OSA on CPAP, bilateral carotid artery stenosis (50-69% stenosis bilaterally), NAFLD w/ cirrhosis, T2DM with neuropathy, OA, depression, PVD, hx of pulmonary nodules present to the hospital with chest pain on 08/10/2021. He was found to have NSTEMI. He was medically treated and d/c'ed home Hosparice on 9/7/21. Pt died at home in home hospice care on 9/24/21. Pt has received covid vaccines 2/14/21 & 3/13/21. This death is likely not related to vaccinations due to comorbidities, age, and length of time from vaccine administration.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Neoplasm malignant
Clinical narrative: Narrative: 71yo patient receiving only mental health from facility died on 9/18/2021. Pt was receiving cancer therapy from outside cancer center. No mention of type of cancer however pt was concerned would be dying soon based on mental notes in chart. Pt also had received covid vaccines on 1/27/21 & 2/24/21 from outside hospital. Likely this death is not related given patient's age, comorbidities, and long length of time between date of vaccines and date of death.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series, 01/21 Pfizer, dose #1 (private) 02/11 Pfizer, dose #2 (private) 07/23 pt cc: cough, fatigue, congestion, rhinorrhea, chills, dyspnea, myalgias, sore throat 08/03 COVID swab, result: detected 08/18 clinically resolved
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series, 01/21 Pfizer, dose #1 (private) 02/11 Pfizer, dose #2 (private) 07/23 pt cc: cough, fatigue, congestion, rhinorrhea, chills, dyspnea, myalgias, sore throat 08/03 COVID swab, result: detected 08/18 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, COVID-19, Chills, Diarrhoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series and after previous COVID infection 01/11/21 pt reported cough, fever up to 103, weakness, decreased appetite, sweats 01/20/21 COVID positive via non-facility test 01/28/21  All sx resolved 02/08/21 Developed new sx on cough and GERD/regurgitation and diarrhea 02/15/21 seen in facility ED, reports testing positive "a few months ago," retested in January and he was negative; c/o body aches and night sweats, diarrhea, vomiting, headache; COVID test positive 05/10/21 Pfizer, dose #1 06/01/21 Pfizer, dose #2 07/13/21 Pt reports diarrhea, cleared up with loperamide 08/03/21 Pt seen in ED w/ c/o LLQ pain, diarrhea x 2 days, nausea but no vomiting COVID positive 08/04/21 pt cc: cough (improving) ,chills, diarrhea, fatigue, headache, myalgia, nausea, vomiting, rhinorrhea 08/09/21 clinically resolved 08/17/21 Pt seen in ED due to runny nose and diarrhea; dx with melena (attributed to chronic cirrhosis)
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Hepatic cirrhosis, Melaena, Myalgia, Nausea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series and after previous COVID infection 01/11/21 pt reported cough, fever up to 103, weakness, decreased appetite, sweats 01/20/21 COVID positive via non-facility test 01/28/21  All sx resolved 02/08/21 Developed new sx on cough and GERD/regurgitation and diarrhea 02/15/21 seen in facility ED, reports testing positive "a few months ago," retested in January and he was negative; c/o body aches and night sweats, diarrhea, vomiting, headache; COVID test positive 05/10/21 Pfizer, dose #1 06/01/21 Pfizer, dose #2 07/13/21 Pt reports diarrhea, cleared up with loperamide 08/03/21 Pt seen in ED w/ c/o LLQ pain, diarrhea x 2 days, nausea but no vomiting COVID positive 08/04/21 pt cc: cough (improving) ,chills, diarrhea, fatigue, headache, myalgia, nausea, vomiting, rhinorrhea 08/09/21 clinically resolved 08/17/21 Pt seen in ED due to runny nose and diarrhea; dx with melena (attributed to chronic cirrhosis)
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Narrative:  COVID infection following COVID vaccine series and after previous COVID infection 01/11/21 pt reported cough, fever up to 103, weakness, decreased appetite, sweats 01/20/21 COVID positive via non-facility test 01/28/21  All sx resolved 02/08/21 Developed new sx on cough and GERD/regurgitation and diarrhea 02/15/21 seen in facility ED, reports testing positive "a few months ago," retested in January and he was negative; c/o body aches and night sweats, diarrhea, vomiting, headache; COVID test positive 05/10/21 Pfizer, dose #1 06/01/21 Pfizer, dose #2 07/13/21 Pt reports diarrhea, cleared up with loperamide 08/03/21 Pt seen in ED w/ c/o LLQ pain, diarrhea x 2 days, nausea but no vomiting COVID positive 08/04/21 pt cc: cough (improving) ,chills, diarrhea, fatigue, headache, myalgia, nausea, vomiting, rhinorrhea 08/09/21 clinically resolved 08/17/21 Pt seen in ED due to runny nose and diarrhea; dx with melena (attributed to chronic cirrhosis)
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID infection following COVID vaccine, 03/27 Janssen dose #1 08/02 COVID swab, pre-op,result: positive 08/04 pt denies symptoms
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 88yo male died on 07/10/2021. No information available about pt's death. Pt had hx of cad/cardiomyopathy/chf(fluid restriction)/6v cabg/pacer-aicd,DM,HTN,TIA,tremor,anemia(MGUS),BCC. Pt had covid vaccines on 2/26/21 & 3/26/21. Likely pt's death is not related to vaccines given pt's age & comorbidities & time in-between vaccines admin & date of death.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Received COVID-19 Moderna vaccine on 12/30/20 and 1/27/21. Breakthrough COVID-19 infection on 8/30/21 (detected in lab result)
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: COVID infection following covid vaccine series 01/11, Pfizer, dose #1 02/02, Pfizer, dose #2 08/30 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea exposure: at weeding 09/01 COVID swab, result: detected 09/01 SARS-COV-2 LINEAGE result: B.1.617.2 09/01 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: COVID infection following covid vaccine series 01/11, Pfizer, dose #1 02/02, Pfizer, dose #2 08/30 pt cc: chills, cough, fatigue, fever, headache, myalgias, rhinorrhea exposure: at weeding 09/01 COVID swab, result: detected 09/01 SARS-COV-2 LINEAGE result: B.1.617.2 09/01 SARS-COV-2 CLADE result: 21 J (DELTA)
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea, Headache, Myalgia
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/03, Pfizer, dose #2 07/24 pt cc: diarrhea, cough, headache, fever, myalgias, sore throat exposure: unknown 08//03 COVID swab, result: detected
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/03, Pfizer, dose #2 07/24 pt cc: diarrhea, cough, headache, fever, myalgias, sore throat exposure: unknown 08//03 COVID swab, result: detected
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac failure congestive, Chronic left ventricular failure, Death
Clinical narrative: Narrative: 78yo male home hospice pt with Hospice Diagnosis:Chronic Systolic (Congestive) Heart Failure died at home on 8/21/2021. Pt had received covid vaccines on 1/29/2021 & 3/1/2021. Death is not related to vaccines
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/13, MODERNA, dose #1 05/11, MODERNA, dose #2 08/03 COVID swab, result: detected 08/04 pt cc: chills, cough, fatigue, headache, rhinorrhea, dyspnea exposure: +COVID wife 08/13 clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Inappropriate schedule of product administration, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/13, MODERNA, dose #1 05/11, MODERNA, dose #2 08/03 COVID swab, result: detected 08/04 pt cc: chills, cough, fatigue, headache, rhinorrhea, dyspnea exposure: +COVID wife 08/13 clinically resolved
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Narrative: 82yo male presented to ER at community hospital on 8/16/21. Pt was admitted with covid positive infection. Pt was treated inpatient with remdesivir & decadron & iv antiviotic. Pt died on 8/20/21 at this hospital. Pt had been vaccinated with covid vaccine on 1/11/21 & 2/4/21.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Drug use disorder
Clinical narrative: Narrative:  55yo male died of unknown causes found by family in his home with suspicion for drug use as cause of death. Patient had received covid vaccines on 4/7/21 & 5/7/21. Death does not appear to be related to vaccines. Pt's problem list below: PROBLEM LAST MOD PROVIDER Methamphetamine dependence (SCT 426873000) 02/27/2020 (ICD-10-CM F15.222) Sleep apnea (SCT 73430006) (ICD-10-CM G47.30) 02/25/2019 History of cocaine abuse (SCT 288791000119106) 02/25/2019 (ICD-10-CM F14.10) Chronic hepatitis C (SCT 128302006) (ICD-10-CM 02/25/2019 B18.2) Nicotine dependence (SCT 56294008) (ICD-10-CM F17.200) Hypertensive disorder (SCT 38341003) (ICD-10-CM 01/25/2019 I10.) Paranoid schizophrenia (SCT 64905009) (ICD-10-CM 01/25/2019 F20.0)
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Swollen tongue
Clinical narrative: Narrative:  03/29/2021 COVID vaccine dose #1 04/19/2021 COVID vaccine dose #2 04/19/2021 Seen in ED for tongue swelling, shortness of breath Per SW note on 4/21/21: Patient reports following COVID-19 vaccine he developed swelling of his tongue and limited breathing and subsequently went to non-affiliated hospital. Treated with "steroids" and symptoms resolved. Not admitted.
Age: 79.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient received the second dose of zoster recombinant vaccination series on 8/24/21 and developed hives. Patient returned to the ER two days later due to the hives and itching. Patient was given methylprednisolone  dose pack and diphenhydramine to help with the itching and hives.
Age: 94.0
Sex: M
Vaccine: VARZOS
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac discomfort, Chest X-ray normal, Chest discomfort, Chest pain, Cold sweat
Clinical narrative: Narrative:  08/04/2021 Patient received Pfizer COVID dose #1 at non-affiliated site, reports experiencing Patient c/o chest pain (described as pressure sensation with heaviness), sob (feeling as if he has to take an extra deep breath and is conscious of needing to take deep breath) and cold sweats since 10 minutes after receiving first pfizer vaccine on Aug 4th at a pharmacy. States was given benadryl x 2 while at the pharmacy which did not help. Called ambulance yesterday due to intense pain and "pounding out of my chest" with difficulty breathing. Evaluated by ED and advised to f/u with cardiology. Patient states "My heart feels like it's too big and heavy." EKG/lab work with chest x-ray. Evaluation was unrevealing. He was recommended to have cardiology consult. Echo and CT chest WNL 08/27/21 Pt reports continued "chest pressure with sweating, light headedness, really feeling incapacitated"
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram thorax normal, Dizziness, Dyspnoea, Echocardiogram normal, Hyperhidrosis
Clinical narrative: Narrative:  08/04/2021 Patient received Pfizer COVID dose #1 at non-affiliated site, reports experiencing Patient c/o chest pain (described as pressure sensation with heaviness), sob (feeling as if he has to take an extra deep breath and is conscious of needing to take deep breath) and cold sweats since 10 minutes after receiving first pfizer vaccine on Aug 4th at a pharmacy. States was given benadryl x 2 while at the pharmacy which did not help. Called ambulance yesterday due to intense pain and "pounding out of my chest" with difficulty breathing. Evaluated by ED and advised to f/u with cardiology. Patient states "My heart feels like it's too big and heavy." EKG/lab work with chest x-ray. Evaluation was unrevealing. He was recommended to have cardiology consult. Echo and CT chest WNL 08/27/21 Pt reports continued "chest pressure with sweating, light headedness, really feeling incapacitated"
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain, Palpitations
Clinical narrative: Narrative:  08/04/2021 Patient received Pfizer COVID dose #1 at non-affiliated site, reports experiencing Patient c/o chest pain (described as pressure sensation with heaviness), sob (feeling as if he has to take an extra deep breath and is conscious of needing to take deep breath) and cold sweats since 10 minutes after receiving first pfizer vaccine on Aug 4th at a pharmacy. States was given benadryl x 2 while at the pharmacy which did not help. Called ambulance yesterday due to intense pain and "pounding out of my chest" with difficulty breathing. Evaluated by ED and advised to f/u with cardiology. Patient states "My heart feels like it's too big and heavy." EKG/lab work with chest x-ray. Evaluation was unrevealing. He was recommended to have cardiology consult. Echo and CT chest WNL 08/27/21 Pt reports continued "chest pressure with sweating, light headedness, really feeling incapacitated"
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Idiopathic pulmonary fibrosis
Clinical narrative: Narrative:  84yo patient died at home on 8/24/21.  Pt was admitted to home hospice on 6/29/21. He had received covid vaccines on 1/11/21 & 2/8/21.Hospice DX: Idiopathic pulmonary fibrosis ICD10). Death not related to vaccinations.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative: HBPC 64yo male with hx of: PROBLEM LIST: *Malnutrition Obstructive sleep apnea of adult Spasticity Constipation Chronic obstructive lung disease Wound Multiple environmental allergies Seen by palliative care service Amyotrophic lateral sclerosis Abnormal findings on diagnostic imaging Sciatic neuropathy Cyst of pancreas Peripheral vascular disease Prediabetes Chronic low back pain Osteoarthritis of knee Degeneration of lumbar intervertebral dis Essential hypertension Hyperlipidemia Gastroesophageal reflux disease Pt was in HBPC as unable to care for self. Pt's family was waiting nursing home placement. Pt DIED at home on 8/24/21. Pt had received covid vaccines on 2/4/21 & 3/8/21. Likely pt's death is not related to vaccines.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/09, Pfizer, dose #2 07/18 pt cc: cough congestion and wheeze, chills exposure: unknown 08/03 COVID swab, result: detected 08/04 clinically resolved
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19, Pfizer, dose #1 04/09, Pfizer, dose #2 07/18 pt cc: cough congestion and wheeze, chills exposure: unknown 08/03 COVID swab, result: detected 08/04 clinically resolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Debridement, Genital erythema, Scrotal pain, Scrotal swelling
Clinical narrative: Narrative: Per inpatient hospice note on 8/26/27: "67 yo male with PMHx of DM, CAD, PVD w/ right BKA and removal of toes on L foot, HTN, chronic combined systolic and diastolic heart failure, HBV, h/o CVA, and ESRD on HD, who presented to the ED on 8/3/21 d/t redness, swelling, and pain of his scrotum debridement on 8/5/21. Palliative care was consulted for Goals of care, Assistance with Advance Directive. Per SW as the patient's NOL/ decision maker. A family meeting was undertaken with the patient and daughter decided to proceed with end of life/comfort care and transfer to the inpt hospice unit. They decided to change the veteran's code status to DNAR with no LST if needed. Defibrillator was deactivated per their request." Pt died on 8/27/21 in inpatient hospice care. Cause of death per inpatient death note was sepsis. Pt had received covid vaccines on 1/6/21 & 2/3/21. Death is not related to covid vaccines.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis
Clinical narrative: Narrative: Per inpatient hospice note on 8/26/27: "67 yo male with PMHx of DM, CAD, PVD w/ right BKA and removal of toes on L foot, HTN, chronic combined systolic and diastolic heart failure, HBV, h/o CVA, and ESRD on HD, who presented to the ED on 8/3/21 d/t redness, swelling, and pain of his scrotum debridement on 8/5/21. Palliative care was consulted for Goals of care, Assistance with Advance Directive. Per SW as the patient's NOL/ decision maker. A family meeting was undertaken with the patient and daughter decided to proceed with end of life/comfort care and transfer to the inpt hospice unit. They decided to change the veteran's code status to DNAR with no LST if needed. Defibrillator was deactivated per their request." Pt died on 8/27/21 in inpatient hospice care. Cause of death per inpatient death note was sepsis. Pt had received covid vaccines on 1/6/21 & 2/3/21. Death is not related to covid vaccines.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Back pain, C-reactive protein increased, COVID-19, Chest X-ray abnormal
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Confusional state, Cough, Dysarthria
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Dysphagia, Dyspnoea, Encephalopathy, Exposure to SARS-CoV-2, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Hemiparesis, Inappropriate schedule of product administration, Laboratory test normal, Lung opacity, Oedema
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Presyncope, Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Somnolence, Swelling
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/02, Pfizer, dose #1 PRIVATE 03/08, Pfizer, dose #2 PRIVATE 03/08 pt cc: neck swelling/angioedma, dysphagia, dyspnea, edema,chest pain; admitted to non-facility hospital due to ADR 08/03 COVID swab, result: detected 08/03 pt cc: cough, fever, chills, body ache, back pain, chest pain 08/10 exposure: +COVID wife 08/17 COVID swab, result: detected 08/19 pt cc: confusion, slurred speech, right sided weakness, fatigue, near syncopal, progressive fatigue; admitted to hospital to r/o CVA 08/21 discharged from hospital after workup negative for CVA; dx: COVID encephalopathy 08/27 reports to PCP less falling asleep while sitting upright and breathing improved appts with Allergy and neuro clinic pending
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Narrative: 82yo died at outside community hospital on 8/24/21. Pt was in active treatment for prostate cancer with plan for hospice care but pt had died before hospice was set up. Pt had received covid vaccines on 1/25/21 & 2/22/21. Vaccines are not related to pt's death.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Condition aggravated, Death, Mantle cell lymphoma, Septic shock
Clinical narrative: Narrative: 71yo pt with hx of cancer, Mantle cell lymphoma of the colon died on healthcare professional 8/26/2021 during inpatient admission. Per Md's death note, "Death was caused by Acute hypoxic respiratory failure secondary to septic shock and worsening malignancy after palliative extubation (consent from family). "Pt had received covid vaccines on 1/27/21 & 3/3/21 from outside hospital. Death is not related to vaccines.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Decreased appetite, Dyspnoea, Nausea
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/04, dose #2 08/01 pt cc: poor appetite, nausea, fever, SOB, and a nonproductive cough exposure: unknown 08/03 COVID swab, result: detected 08/09 clinically resolved
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 02/11, Pfizer, dose #1 03/04, dose #2 08/01 pt cc: poor appetite, nausea, fever, SOB, and a nonproductive cough exposure: unknown 08/03 COVID swab, result: detected 08/09 clinically resolved
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Headache, Oropharyngeal pain
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 08/02 pt cc: chills, cough, fever, headache, rhinorrhea, sore throat exposure: unknown 08/03 COVID swab, result: detected 08/17 clinically resolved
Age: 92.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/14, Pfizer, dose #1 02/04, Pfizer, dose #2 08/02 pt cc: chills, cough, fever, headache, rhinorrhea, sore throat exposure: unknown 08/03 COVID swab, result: detected 08/17 clinically resolved
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Flushing, Rash, Skin warm
Clinical narrative: Reddened neck and chest. Warm to touch, flushing of face within 15 minutes of vaccine. Patent airway. Pt to take PO Benadryl. Offered to call EMS pt declined. Patient stable, rash fading prior to her leaving.
Sex: F
Vaccine: COVID19
Symptoms: Death, Incomplete course of vaccination
Clinical narrative: Knew 2 girls that didn't take their 2nd dose & died; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Knew 2 girls that didn't take their 2nd dose & died) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant product was not provided by the reporter  Treatment information was not provided  Company's comment: This is a spontaneous report concerning a female patient of unknown age and medical history. The reporter mentions that knew the patient and that she hadn't taken the second dose of the vaccine and died. The date of vaccination and manufacturer were not reported, nor was cause of death. No further information was disclosed. A query was raised requesting any information that can be provided to further elucidate this case.   This case was linked to MOD-2021-395659, MOD-2021-395672 (Patient Link).; Sender's Comments: This is a spontaneous report concerning a female patient of unknown age and medical history. The reporter mentions that knew the patient and that she hadn't taken the second dose of the vaccine and died. The date of vaccination and manufacturer were not reported, nor was cause of death. No further information was disclosed. A query was raised requesting any information that can be provided to further elucidate this case.; Reported Cause(s) of Death: Unknown cause of death
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Death
Clinical narrative: Narrative:  Patient had a PMH of type 2 diabetes mellitus, hyperlipidemia, PTSD, tremor, COPD/coal workers pneumoconiosis, hypertension, hip/joint pain, and obesity Patient received both the Moderna COVID booster and the Quadrivalent preservative free (Afluria) influenza vaccine on 11/4/21 Received 1st dose of Moderna COVID Vaccine on 2/13/21, 2nd dose on 3/13/21, 3rd (booster) dose on 11/4/21, Primary care nurse contacted patient's residence 11/5/21 to discuss knee x-ray findings. Patient's wife informed nurse that patient had passed away the night before on 11/4/21. Cause of death or other information currently not available at time of this report.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Muscle disorder, Muscle tightness, Muscular weakness, Myalgia
Clinical narrative: Narrative:  On 8/24/21: "Since I had the Covid shot my muscles have declined. I am worried about my upper body muscle weakness. My neck seems tight, I am not able to turn and look as well. My arm muscles are aching and very weak. I can barely pick up one of our dinner plates. I have even tried the patches you prescribed for my lower back pain to no avail. My wrists are nearly useless...I cannot even open a bottle of water, my wife is having to do that for me. I am worried."
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Narrative:  On 8/24/21: "Since I had the Covid shot my muscles have declined. I am worried about my upper body muscle weakness. My neck seems tight, I am not able to turn and look as well. My arm muscles are aching and very weak. I can barely pick up one of our dinner plates. I have even tried the patches you prescribed for my lower back pain to no avail. My wrists are nearly useless...I cannot even open a bottle of water, my wife is having to do that for me. I am worried."
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Cough, Diarrhoea
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/30/21 COVID vaccine dose #1 (J&J) 08/02/21 Pt presents to ED reporting exposure to patient with respiratory symptoms ~12 days ago (07/21); states he has symptoms of malaise, body aches, subjective fevers, cough, SOB, and 1-2 loose stools/day for the past 9 days (07/25); CXR bilateral pneumonia, inflammatory markers slightly elevated; admitted for COVID pneumonia; COVID POSITIVE 08/03/21 Treated inpatient with dexamethasone, remdesivir, albuterol/ipratropium 08/05/21 Pt requires oxygen on and off, mainly at night time 08/06/21 Pt discharged home with rx for famotidine, dexamethasone, and albuterol/ipratropium
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Exposure to communicable disease, Inflammatory marker increased, Malaise, Pain
Clinical narrative: Narrative: COVID infection following completion of COVID vaccine series 03/30/21 COVID vaccine dose #1 (J&J) 08/02/21 Pt presents to ED reporting exposure to patient with respiratory symptoms ~12 days ago (07/21); states he has symptoms of malaise, body aches, subjective fevers, cough, SOB, and 1-2 loose stools/day for the past 9 days (07/25); CXR bilateral pneumonia, inflammatory markers slightly elevated; admitted for COVID pneumonia; COVID POSITIVE 08/03/21 Treated inpatient with dexamethasone, remdesivir, albuterol/ipratropium 08/05/21 Pt requires oxygen on and off, mainly at night time 08/06/21 Pt discharged home with rx for famotidine, dexamethasone, and albuterol/ipratropium